dalteparin has been researched along with Blood Platelet Disorders in 2 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Blood Platelet Disorders: Disorders caused by abnormalities in platelet count or function.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kligman, MD | 1 |
| Zyromski, NJ | 1 |
| McCullough, DG | 1 |
| Gunning, WT | 1 |
| Or, R | 1 |
| Elad, S | 1 |
| Shpilberg, O | 1 |
| Eldor, A | 1 |
1 trial available for dalteparin and Blood Platelet Disorders
| Article | Year |
|---|---|
Low molecular weight heparin stimulates megakaryocytopoiesis in bone-marrow transplantation patients.
Topics: Anticoagulants; Biological Availability; Blood Platelet Disorders; Bone Marrow Transplantation; Enox | 1996 |
1 other study available for dalteparin and Blood Platelet Disorders
| Article | Year |
|---|---|
Platelet-dense granule deficiency causes postoperative hemorrhage in patients receiving enoxaparin: a novel observation with dramatic clinical implications.
Topics: Adult; Anticoagulants; Blood Platelet Disorders; Cytoplasmic Granules; Enoxaparin; Gastric Bypass; H | 2009 |